Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Brucella suis biovar 1 (strain 1330) | Histidinol dehydrogenase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Candida albicans | Phosphoribosyl-AMP cyclohydrolase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium ulcerans | histidinol dehydrogenase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium leprae | Probable histidinol dehydrogenase HisD (HDH) | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Candida albicans | Phosphoribosyl-AMP cyclohydrolase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0124 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0013 | 0.0044 | 0.3523 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.0124 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0124 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0124 | 0.5 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0124 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0124 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0124 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0124 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.002 | 0.0124 | 0.008 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0124 | 0.5 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0124 | 0.5 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0124 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0124 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0124 | 0.5 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.0124 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0124 | 0.5 |
Mycobacterium ulcerans | histidinol dehydrogenase | 0.0876 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0013 | 0.0044 | 0.3523 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.0124 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0124 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0013 | 0.0044 | 0.3523 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0124 | 0.5 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0.0124 | 0.5 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | 0.0876 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.